Substance use and psychiatric symptoms in subjects referred to the Drug Addiction Services by the Prefecture [2];Uso di sostanze e sintomatologia psichiatrica in soggetti segnalati ai servizi per le Dipendenze dalla Prefettura

Epidemiologia e Psichiatria Sociale

Volumn 16, Issue 1, 2007, Pages 73-78

  Bizzarri, Jacopo V ^a   Rucci, Paola ^b   Casalboni, Daniela ^c   Randi, Saverio ^c   Girelli, Massimo ^a   Pojer, Francesca ^a   Sbrana, Alfredo ^b  

^a Servizio per le Dipendenze   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c AUSL of Rimini   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH SERVICE; SUBSTANCE ABUSE;

EID: 34047247351     PISSN: 1121189X     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1121189x00004632     Document Type: Letter

References (20)

1. Bizzarri J.V., Rucci P., Sbrana A., Gonnelli C., Massei G.J., Ravani L., Girelli M., Dell'Osso L. & Cassano G.B. (in press). Reasons for substance use and vulnerability factors in patients with substance use disorder and anxiety or mood disorders, Addictive Behaviors.
2. Bovasso G.B. (2001). Cannabis abuse as a risk factor for depressive symptoms. American Journal of Psychiatry 158, 2033-2037.
3. Cassano G.B., Frank E., Miniati M., Fagiolini A., Pini S., Rucci P. & Maser J.D. (2002). Conceptual underpinnings and empirical support for the mood spectrum. Psychiatric Clinics of North America 25, 699-712.
4. Chabrol H., Ducongé E., Casas C., Roura C. & Carey K.B. (2005). Relations between cannabis use and dependence, motives for cannabis use and anxious, depressive and borderline symptomatology. Addictive Behaviors 30, 829-840.
5. Clerici M., Carta I. & Cazzullo C.L. (1989). Substance abuse and psychopathology: a diagnostic screening of Italian narcotic addicts. Social Psychiatry and Psychiatric Epidemiology 24, 219-226.
6. Conway K.P., Swendsen J.D., Rounsaville B.J. & Merikangas K.R. (2002). Personality, drug of choice, and comorbid psychopathology among substance abusers. Drug and Alcohol Dependence 65, 225-234.
7. Degenhardt L., Hall W. & Lynskey M. (2001). The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-Being. Social Psychiatry and Psychiatric Epidemiology 36, 219-227.
8. Dipartimento Nazionale per le Politiche Antidroga (DNPA) - Ufficio per il Monitoraggio (2005). Relazione Annuale al Parlamento sullo Stato delle Tossicodipendenze in Italia nel 2005.
9. Galizio M. & Stein F.S. (1983). Sensation seeking and drug choice. International Journal of the Addiction 18, 1039-1048.
10. Kalbag A.S. & Levin F.R. (2005). Adult ADHD and substance abuse: diagnostic and treatment issues. Substance Use & Misuse 40, 1955-1981.
11. Kantojarvi L., Veijola J., Laksy K., Jokelainen J., Herva A., Karvonen J.T., Kokkonen P., Jarvelin M.R. & Joukamaa M. (2006). Co-occurrence of personality disorders with mood, anxiety, and substance use disorders in a young adult population. Journal of Personality Disorders 20, 102-112.
12. Kessler R.C., Adler L., Barkley R., Biederman J., Conners C.K., Demler O., Faraone S.V., Greenhill L.L., Howes M.J., Secnik K., Spencer T., Ustun T.B., Walters E.E. & Zaslavsky A.M. (2006). The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. American Journal of Psychiatry 163, 716-723.
13. Pozzi G., Bacigalupi M. & Tempesta E. (1997). Comorbidity of drug dependence and other mental disorders: a two-phase study of prevalence at outpatient treatment centres in Italy. Drug and Alcohol Dependence 46, 69-77.
14. Pozzi G., Frustaci A., Janiri L. & Di Giannantonio M. (2006). The challenge of psychiatric comorbidity to the public services for drug dependence in Italy: A national survey. Drug and Alcohol Dependence 82, 224-230.
15. Rey J.M., Sawyer M.G., Raphael B., Patton G.C. & Lynskey M. (2002). Mental health of teen-agers who use cannabis. Results of an Australian survey. British Journal of Psychiatry 180, 216-221.
16. Rucci P., Frank E., Fagiolini A., Kupfer D.J., Shear M.K., Dell'Osso L., Banti S., Mauri M., Grochocinski V.J., Maser J.D., Endicott J. & Cassano G.B. (2003). Development and preliminary testing of the General 5-Spectrum Measure (GSM-V). Depression and Anxiety 18, 109-117.
17. Sbrana A., Dell'Osso L., Gonnelli C., Impagnatiello P., Doria M.R., Spagnolli S., Ravani L., Cassano G.B., Frank E., Shear M.K., Grochocinski V.J., Rucci P., Maser J.D. & Endicott J. (2003). Acceptability, validity and reliability of the Structured Clinical Interview for the Spectrum of Substance Use (SCI-SUBS): a pilot study. International Journal of Methods in Psychiatric Research 12, 105-115.
18. Siliquini R., Faggiano F., Geniatti S., Versino E., Mitola B. & Ippolito R. (2001). Patterns of drug use among young men in Piedmont (Italy). Drug and Alcohol Dependence 64, 329-335.
19. Troisi A., Pasini A., Saracco M. & Spalletta G. (1998). Psychiatric symptoms in males cannabis users not using other illicit drugs. Addiction 93, 487-492.
20. Volkow N. (2005). What do we know about drug addiction. American Journal of Psychiatry 162, 1401-1402.